- Home
- WAFU vs LGVN Comparison
WAFU vs LGVN Comparison
Compare WAFU & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- LGVN
- Stock Information
- Founded
- WAFU 1999
- LGVN 2014
- Country
- WAFU China
- LGVN United States
- Employees
- WAFU N/A
- LGVN N/A
- Industry
- WAFU Other Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- WAFU Real Estate
- LGVN Health Care
- Exchange
- WAFU Nasdaq
- LGVN Nasdaq
- Market Cap
- WAFU 8.8M
- LGVN 30.0M
- IPO Year
- WAFU 2019
- LGVN 2021
- Fundamental
- Price
- WAFU $1.84
- LGVN $2.05
- Analyst Decision
- WAFU
- LGVN Strong Buy
- Analyst Count
- WAFU 0
- LGVN 2
- Target Price
- WAFU N/A
- LGVN $8.00
- AVG Volume (30 Days)
- WAFU 59.4K
- LGVN 393.9K
- Earning Date
- WAFU 01-01-0001
- LGVN 11-08-2024
- Dividend Yield
- WAFU N/A
- LGVN N/A
- EPS Growth
- WAFU N/A
- LGVN N/A
- EPS
- WAFU N/A
- LGVN N/A
- Revenue
- WAFU $7,223,220.00
- LGVN $1,229,000.00
- Revenue This Year
- WAFU N/A
- LGVN $161.78
- Revenue Next Year
- WAFU N/A
- LGVN $8.62
- P/E Ratio
- WAFU N/A
- LGVN N/A
- Revenue Growth
- WAFU N/A
- LGVN 39.34
- 52 Week Low
- WAFU $1.58
- LGVN $0.77
- 52 Week High
- WAFU $2.85
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- WAFU 49.50
- LGVN 52.20
- Support Level
- WAFU $1.77
- LGVN $1.76
- Resistance Level
- WAFU $1.91
- LGVN $2.26
- Average True Range (ATR)
- WAFU 0.14
- LGVN 0.12
- MACD
- WAFU -0.02
- LGVN 0.05
- Stochastic Oscillator
- WAFU 17.19
- LGVN 58.00
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.